Determinants of health-related quality of life in Crohn's disease: A systematic review and meta-analysis

Journal of Crohn's and Colitis

Volumn 8, Issue 2, 2014, Pages 93-106

  Van der Have, Mike ^a   van der Aalst, Karen S ^a   Kaptein, Ad A ^b   Leenders, Max ^a   Siersema, Peter D ^a   Oldenburg, Bas ^a   Fidder, Herma H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Crohn's disease; Determinants; Health related quality of life; Patient reported outcomes; Systematic review

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; CORTICOSTEROID; INFLIXIMAB; NATALIZUMAB;

AGE; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE DURATION; DISTRESS SYNDROME; FEMININITY; HOSPITALIZATION; HUMAN; META ANALYSIS; MULTICENTER STUDY (TOPIC); PERSONALITY; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SMOKING; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; WORK DISABILITY;

CROHN'S DISEASE; DETERMINANTS; HEALTH-RELATED QUALITY OF LIFE; PATIENT-REPORTED OUTCOMES; SYSTEMATIC REVIEW;

ADRENAL CORTEX HORMONES; AGE FACTORS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; EMPLOYMENT; HEALTH STATUS; HOSPITALIZATION; HUMANS; QUALITY OF LIFE; RECURRENCE; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84892897596     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.04.007     Document Type: Review

References (65)

1. Peyrin-Biroulet L., Loftus E.V., Colombel J.F., Sandborn W.J. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010, 105:289-297.
2. Love J.R., Irvine E.J., Fedorak R.N. Quality of life in inflammatory bowel disease. J Clin Gastroenterol 1992, 14:15-19.
3. Schipper H., Clinch J.J., Olweny C.L.M. Quality of life studies: definitions and conceptual issues. Quality of Life and Pharmacoeconomics in Clinical Trials 1996, 11-23. Lippincott-Raven Press, Philadelphia. ed. 2. B. Spilker (Ed.).
4. Cohen R.D. The quality of life in patients with Crohn's disease. Aliment Pharmacol Ther 2002, 16:1603-1609.
5. Sainsbury A., Heatley R.V. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005, 21:499-508.
6. Mussel, Böcker U., Nagel N., Singer M.V. Predictors of disease related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004, 16:1273-1280.
7. Graff L.A., Walker J.R., Lix L., Clara I., Rawsthorne P., Rogala L., et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 2006, 4:1491-1501.
8. Altman D.G. Systematic reviews of evaluations of prognostic variables. BMJ 2001, 323:224-228.
9. Eisen G.M., Locke G.R., Provenzale D. Health-related quality of life: a primer for gastroenterologists. Am J Gastroenterol 1999, 94:2017-2021.
10. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gøtzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700.
11. Hayden J.A., Côté P., Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006, 144:427-437.
12. R Development Core Team R: a language and environment for statistical computing 2008, R Foundation for Statistical Computing, Vienna, Austria, [URL http://www.R-project.org].
13. Ananthakrishnan A.N., Weber L.R., Knox J.F., Skaros S., Emmons J., Lundeen S., et al. Permanent work disability in Crohn's disease. Am J Gastroenterol 2008, 103:154-161.
14. Andersson P., Olaison G., Bendtsen P., Myrelid P., Sjodahl R. Health related quality of life in Crohn's proctocolitis does not differ from a general population when in remission. Colorectal Dis 2003, 5:56-62.
15. Banovic I., Gilibert D., Cosnes J. Crohn's disease and fatigue: constancy and co-variations of activity of the disease, depression, anxiety and subjective quality of life. Psychol Health Med 2010, 15:394-405.
16. Bernklev T., Jahnsen J., Henriksen M., Lygren I., Aadland E., Sauar J., et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:402-412.
17. Bernklev T., Jahnsen J., Aadland E., Sauar J., Schulz T., Lygren I., et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004, 4:365-373.
18. Bernklev T., Jahnsen J., Schulz T., Sauar J., Lygren I., Henriksen M., et al. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5years after initial diagnosis. Eur J Gastroenterol Hepatol 2005, 17:1037-1045.
19. Blondel-Kucharski F., Chircop C., Marquis P., Cortot A., Baron F., Gendre J.P., et al. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol 2001, 96:2915-2920.
20. Boye B., Jahnsen J., Mokleby K., Leganger S., Jantschek G., Jantschek I., et al. The INSPIRE study: are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's diseaseα. Inflamm Bowel Dis 2008, 14:680-686.
21. Canavan C., Abrams K.R., Hawthorne B., Drossman D., Mayberry J.F. Long-term prognosis in Crohn's disease: factors that affect quality of life. Aliment Pharmacol Ther 2006, 23:377-385.
22. Casellas F., Arenas J.I., Baudet J.S., Fábregas S., García N., Gelabert J., et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis 2005, 11:488-496.
23. Casellas F., López-Vivancos J., Sampedro M., Malagelada J.R. Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life. Am J Gastroenterol 2005, 100:2737-2742.
24. Casellas F., López-Vivancos J., Badia X., Vilaseca J., Malagelada J. Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol 2001, 13:567-572.
25. Drossman D.A., Patrick D.L., Mitchell C.M., Zagami E.A., Appelbaum M.I. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989, 34:1379-1386.
26. Feagan B.G., Coteur G., Tan S., Keininger D.L., Schreiber S. Clinically meaningful improvement in health-related quality of life in a randomized controlled trial of certolizumab pegol maintenance therapy for Crohn's disease. Am J Gastroenterol 2009, 104:1976-1983.
27. Gibson P.R., Weston A.R., Shann A., Florin T.H., Lawrance I.C., Macrae F.A., et al. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease. J Gastroenterol Hepatol 2007, 22:1306-1312.
28. Guassora A.D., Kruuse C., Thomsen O.O., Binder V. Quality of life study in a regional group of patients with Crohn's disease. A structured interview study. Scand J Gastroenterol 2000, 35:1068-1074.
29. Høivik M.L., Bernklev T., Solberg I.C., Cvancarova M., Lygren I., Jahnsen J., et al. Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study. J Crohns Colitis 2012, 6:441-453.
30. Iglesias M., Vazquez I., Barreiro-de Acosta M., Figueiras A., Nieto L., Piñeiro M., et al. Health related quality of life in patients with Crohn's disease in remission. Rev Esp Enferm Dig 2010, 102:624-630.
31. Jaghult S., Saboonchi F.J., Unn B., Wredling R., Kapraali M. Identifying predictors of low health-related quality of life among patients with inflammatory bowel disease: comparison between Crohn's disease and ulcerative colitis with disease duration. J Clin Nurs 2011, 20:1578-1587.
32. Loftus E.V., Feagan B.G., Colombel J.F., Rubin D.T., Wu E.Q., Yu A.P., et al. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial. Am J Gastroenterol 2008, 103:3132-3141.
33. Maunder R., Toner B., de Rooy E., Moskovitz D. Influence of sex and disease on illness-related concerns in inflammatory bowel disease. Can J Gastroenterol 1999, 13:728-732.
34. Romberg-Camps M.J., Bol Y., Dagnelie P.C., Hesselink-van de Kruijs M.A., Kester A.D., Engels L.G., et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 2010, 16:2137-2147.
35. Russel M.G., Nieman F.H., Bergers J.M., Stockbrügger R.W. Cigarette smoking and quality of life in patients with inflammatory bowel disease. South Limburg IBD Study Group. Eur J Gastroenterol Hepatol 1996, 8:1075-1081.
36. Schirbel A., Reichert A., Roll S., Baumgart D.C., Büning C., Wittig B., et al. Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol 2010, 16:3168-3177.
37. Stjernman H., Tysk C., Almer S., Strom M., Hjortswang H. Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scand J Gastroenterol 2010, 45:696-706.
38. Straus W.L., Eisen G.M., Sandler R.S., Murray S.C., Sessions J.T. Crohn's disease: does race matterα The Mid-Atlantic Crohn's Disease Study Group. Am J Gastroenterol 2000, 95:479-483.
39. Van der Eijk I., Vlachonikolis I.G., Munkholm P., Nijman J., Bernklev T., Politi P., et al. The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis 2004, 10:392-398.
40. Feagan B.G., Yan S., Bala M., Bao W., Lichtenstein G.R. The effects of infliximab maintenance therapy on health-related quality of life. Am J Gastroenterol 2003, 98:2232-2238.
41. Feagan B.G., Sandborn W.J., Hass S., Niecko T., White J. Health-related quality of life during natalizumab maintenance therapy for Crohn's disease. Am J Gastroenterol 2007, 102:2737-2746.
42. Tillinger W., Mittermaier C., Lochs H., Moser G. Health-related quality of life in patients with Crohn's disease: influence of surgical operation - a prospective trial. Dig Dis Sci 1999, 44:932-938.
43. Solberg I.C., Vatn M.H., Hoie O., Stray N., Sauar J., Jahnsen J., et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow up study. Clin Gastroenterol Hepatol 2007, 5:1430-1438.
44. Rutgeerts P., Geboes K., Vantrappen G., Beyls J., Kerremans R., Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990, 99:956-963.
45. Dhillon S.L., Loftus E.V., Tremaine W.J. The natural history of surgery for Crohn's disease in a population-based cohort from Olmsted County, Minnesota (Abstract 825). Am J Gastroenterol 2005, 100:S305.
46. Moser G., Tillinger W., Sachs G., Genser D., Maier-Dobersberger T., Spiess K., et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995, 7:853-858.
47. Wijnhoven H.A.H., Kriegsman D.M., Snoek F.J., Hesselink A.E., de Haan M. Gender differences in health-related quality of life among asthma patients. J Asthma 2003, 40:189-199.
48. Dowdy S.W., Dwyer K.A., Smith C.A., Wallston K.A. Gender and psychological well-being of persons with rheumatoid arthritis. Arthritis Care Res 1996, 9:449-456.
49. Petterson T., Lee P., Hollis S., Young B., Newton P., Dornan T. Well-being and treatment satisfaction in older people with diabetes. Diabetes Care 1998, 21:930-935.
50. Stewart A.L., Hays R.D., Ware J.E. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988, 26:724-735.
51. Dorrian A., Dempster M., Adair P. Adjustment to inflammatory bowel disease: the relative Influence of illness perceptions and coping. Inflamm Bowel Dis 2009, 15:47-55.
52. Han S.W., McColl E., Barton J.R., James P., Steen I.N., Welfare M.R. Predictors of quality of life in ulcerative colitis. The importance of symptoms and illness representations. Inflamm Bowel Dis 2005, 11:24-34.
53. Rochelle T.L., Fidler H. The importance of illness perceptions, quality of life and psychological status in patients with ulcerative colitis and Crohn's disease. J Health Psychol Oct 1 2012, [Epub ahead of print]. 10.1177/1359105312459094.
54. Guthrie E., Jackson J., Shaffer J., Thompson D., Tomenson B., Creed F. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol 2002, 97:1994-1999.
55. Vidal A., Gómez-Gil E., Sans M., Portella M.J., Salamero M., Piqué J.M., et al. Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality. Inflamm Bowel Dis 2008, 14:977-983.
56. Janke K.H., Klump B., Gregor M., Meisner C., Haeuser W. Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis 2003, 11:272-286.
57. Feagan B.G., Bala M., Yan S., Olson A., Hanauer S. Unemployment and disability in patients with moderately to severely active Crohn's disease. J Clin Gastroenterol 2005, 39:390-395.
58. Boonen A., Dagnelie P.C., Feleus A., Hesselink M.A., Muris J.W., Stockbrügger R.W., et al. The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis 2002, 8:382-389.
59. Bernstein C.N., Kraut A., Blanchard J.F., Rawsthorne P., Yu N., Walld R. The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol 2001, 96:2117-2125.
60. Sonnenberg A. Disability and need for rehabilitation among patients with inflammatory bowel disease. Digestion 1992, 51:168-178.
61. Stjernman H., Tysk C., Almer S., Ström M., Hjortswang H. Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease. Eur J Gastroenterol Hepatol 2011, 23:671-679.
62. van der Valk M.E., Mangen M.J., Leenders M., Dijkstra G., van Bodegraven A.A., Fidder H.H., et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study. Gut 2012, 10.1136/gutjnl-2012-303376.
63. Høivik M.L., Moum B., Solberg I.C., Henriksen M., Cvancarova M., Bernklev T., et al. Work disability in inflammatory bowel disease patients 10years after disease onset: results from the IBSEN Study. Gut 2013, 10.1136/gutjnl-2012-302311.
64. Singleton J.W., Law D.H., Kelley M.L., Mekhjian H.S., Sturdevant R.A. National Cooperative Crohn's Disease Study: adverse reactions to study drugs. Gastroenterology 1979, 77:870-882.
65. De Boer A., Sprangers M., Bartelsman J., de Haes H. Predictors of health care utilization in patients with inflammatory bowel disease: a longitudinal study. Eur J Gastroenterol Hepatol 1998, 10:783-789.